Reduced TCA flux in diabetic myotubes: Determined by single defects?

Biochemistry Research International

Volumn , Issue , 2012, Pages

  Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859722848     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2012/716056     Document Type: Article

References (27)

1. Gaster M., Petersen I., Hojlund K., Poulsen P., Beck-Nielsen H., The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity Diabetes 2002 51 4 921 927 (Pubitemid 34438332)
2. Gaster M., Rustan A. C., Aas V., Beck-Nielsen H., Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes Diabetes 2004 53 3 542 548 (Pubitemid 38270621)
3. Gaster M., Rustan A. C., Beck-Nielsen H., Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes Diabetes 2005 54 3 648 656 (Pubitemid 40322066)
4. Gaster M., Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects Biochemical and Biophysical Research Communications 2009 382 4 766 770
5. Wensaas A. J., Rustan A. C., Just M., Berge R. K., Drevon C. A., Gaster M., Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of β-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid Diabetes 2009 58 3 527 535
6. Gaster M., Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes Biochimica et Biophysica Acta 2007 1772 7 755 765 (Pubitemid 46891212)
7. Gaster M., Reduced TCA flux in diabetic myotubes: a governing influence on the diabetic phenotype? Biochemical and Biophysical Research Communications 2009 387 4 651 655
8. Janssen A. J., Trijbels F. J., Sengers R. C., Wintjes L. T. M., Ruitenbeek W., Smeitink J. A. M., Morava E., Van Engelen B. G. M., Van Den Heuvel L. P., Rodenburg R. J. T., Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology Clinical Chemistry 2006 52 5 860 871 (Pubitemid 43673265)
9. Befroy D. E., Petersen K. F., Dufour S., Mason G. F., De Graaf R. A., Rothman D. L., Shulman G. I., Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients Diabetes 2007 56 5 1376 1381 (Pubitemid 46715630)
10. Schrauwen P., Hesselink M. K., Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus? Diabetologia 2008 51 9 1694 1697
11. Gaster M., Beck-Nielsen H., Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects Biochimica et Biophysica Acta 2006 1761 1 100 110
12. Ortenblad N., Mogensen M., Petersen I., Hjlund K., Levin K., Sahlin K., Beck-Nielsen H., Gaster M., Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect Biochimica et Biophysica Acta 2005 1741 1-2 206 214 (Pubitemid 40825006)
13. Minet A. D., Gaster M., ATP synthesis is impaired in isolated mitochondria from myotubes established from type 2 diabetic subjects Biochemical and Biophysical Research Communications 2010 402 1 70 74
14. Minet A. D., Gaster M., The dynamic equilibrium between ATP synthesis and ATP consumption is lower in isolated mitochondria from myotubes established from type 2 diabetic subjects compared to lean control Biochemical and Biophysical Research Communications 2011 409 591 595
15. Thingholm T. E., Bak S., Beck-Nielsen H., Jensen O. N., Gaster M., Characterization of human myotubes from type 2 diabetic and non-diabetic subjects using complementary quantitative mass spectrometric methods Molecular Cellular Proteomics 2011 10
16. Minet A. D., Gaster M., Hydrogen peroxide production is not primarily increased in human myotubes established from type 2 diabetic subjects Journal of Clinical Endocrinology Metabolism 2011 96 E1486 E1490
17. Gaster M., Beck-Nielsen H., The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic originevidence from cultured myotubes Biochimica et Biophysica Acta 2004 1690 1 85 91 (Pubitemid 39150027)
18. Gaster M., Kristensen S. R., Beck-Nielsen H., Schroder H. D., A cellular model system of differentiated human myotubes Acta Pathologica, Microbiologica et Immunologica Scandinavica 2001 109 11 735 744 (Pubitemid 34015455)
19. Gaster M., Schroder H. D., Handberg A., Beck-Nielsen H., The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure Biochimica et Biophysica Acta 2001 1537 3 211 221 (Pubitemid 33139803)
20. Gaster M., Beck-Nielsen H., Schroder H. D., Proliferation conditions for human satellite cells. The fractional content of satellite cells Acta Pathologica, Microbiologica et Immunologica Scandinavica 2001 109 11 726 734 (Pubitemid 34015454)
21. Gaster M., Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes Biochimica et Biophysica Acta 2007 1772 7 755 765 (Pubitemid 46891212)
22. Frederiksen C. M., Hojlund K., Hansen L., Oakeley E. J., Hemmings B., Abdallah B. M., Brusgaard K., Beck-Nielsen H., Gaster M., Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes Diabetologia 2008 51 11 2068 2077
23. Patti M. E., Butte A. J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E. J., Goldfine A. B., Mun E., DeFronzo R., Finlayson J., Kahn C. R., Mandarino L. J., Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1 Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8466 8471 (Pubitemid 36842568)
24. Mootha V. K., Lindgren C. M., Eriksson K. F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrle M., Laurila E., Houstis N., Daly M. J., Patterson N., Mesirov J. P., Golub T. R., Tamayo P., Spiegelman B., Lander E. S., Hirschhorn J. N., Altshuler D., Groop L. C., PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes Nature Genetics 2003 34 3 267 273 (Pubitemid 36792858)
25. Lin G., Brownsey R. W., MacLeod K. M., Regulation of mitochondrial aconitase by phosphorylation in diabetic rat heart Cellular and Molecular Life Sciences 2009 66 5 919 932
26. Gaster M., Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes Biochemical and Biophysical Research Communications 2011 404 1023 1028
27. Abdul-Ghani M. A., Jani R., Chavez A., Molina-Carrion M., Tripathy D., De Fronzo R. A., Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants Diabetologia 2009 52 4 574 582